Indivior PLC (LSE:INDV) - Overview

Stock Report

Indivior PLC INDV

Last Price
GBX296.30

Day Change
1.80|0.61%

As of 09/12/2016
09:37:02 GMT | GBX
Minimum 15 Minutes Delay.

Last Close294.50p
Day Range292.80 - 299.50
Mkt Cap2.12Bil
52-Wk Range126.60 - 377.00
Yield %0.70
ISINGB00BRS65X63
Volume196,392
P/E12.46
P/S3.11
P/CF9.86

Share Price

Total Returns 08/12/2016

 Chg (%)  
More ...
Indivior PLC-15.95 
FTSE 100 TR GBP1.73
 
Financials
201320142015
More ...
Income Statement
Turnover781.09678.46684.44
Operating Profit446.43341.97233.55
Net Profit314.11245.22153.90
Reported EPS43.6834.0820.93
Balance Sheet
Current Assets138.27363.00486.67
Non Current Assets120.07116.93145.80
Total Assets258.34479.93632.47
Current Liabilities273.50296.83407.02
Total Liabilities298.36785.11820.79
Total Equity-40.02-305.18-188.32
Cash Flow
Operating Cash Flow574.26303.63334.12
Net Change in Cash-11.56197.1597.87
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016169.1825.095.5211.742.13--
2017138.4223.93-4.6412.31-2.65--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
29/07/2016in Lieu of DividendMs. Lorna Parker299.91114342.00
29/07/2016in Lieu of DividendMr. Daniel Phelan299.91193579.00
29/07/2016in Lieu of DividendMr. Shaun Thaxter299.918,08224,239.00
29/07/2016in Lieu of DividendMr. Tom McLellan299.91143429.00

Company Profile

Indivior PLC is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence.
 

Sector

Drug Manufacturers - Specialty & Generic

Market Position

167 of 1865 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Outlook

(02/11/2016) ceo - "Our performance this year to date continues to be strong"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)12.2713.3915.97
Div Yld (E)0.004.244.18
PEG (E)-3.040.220.27
ROCE120.26204.18-30.67
Op Mrgn36.29-17.37-33.06
EPS Grwth-4.049.7722.66
Dividends
PreviousLatest
More ...
Record Date18/09/1517/06/16
Ex-Div17/09/1516/06/16
Paid23/10/1529/07/16
Amnt2.087.30

Broker Sentiment

Strong Buy0
Buy1
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Howard Pien
Chief Executive OfficerMr. Shaun Thaxter
Chief Financial OfficerMr. Cary Claiborne
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.